Shionogi scraps plan to acquire Victory
This article was originally published in Scrip
Executive Summary
Shionogi's US subsidiary Sciele Pharma has decided not to move ahead with its planned acquisition of the privately held US firm Victory Pharma, for unspecified reasons.